You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally adcanced

Showing 1 - 25 of 5,216
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial in Changsha (Camrelizumab, Albumin Paclitaxel, Carboplatin)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Camrelizumab, Albumin Paclitaxel, Carboplatin
  • Changsha, Hunan, China
    Wenxiang Wang
Feb 19, 2021

Exploration of Locally Recurrent Colorectal Cancer

Recruiting
  • Locally Recurrent Colorectal Cancer
  • salvage surgery
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences & Peking Un
Oct 28, 2023

The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

Recruiting
  • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
  • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
  • Hanzhou, Zhejiang, China
    Lulu Liu
Jul 14, 2023

Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)

Recruiting
  • Rectal Neoplasms
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Aug 27, 2023

NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Esophageal Cancer
  • +10 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Breast Cancer
  • +4 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)

Recruiting
  • Prostate Cancer
  • +3 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)

Not yet recruiting
  • Her2-positive/Low-expression Urinary and Digestive Tract Tumors
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 8, 2023

Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

Recruiting
  • Differentiated Thyroid Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 9, 2023

Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Endostar and Envafolimab
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 24, 2023

Cervical Cancer Trial (Adebrelimab)

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
Nov 28, 2023

Locally Advanced Rectal Cancer, Locally Recurrent Rectal Cancer Trial in Southampton (Intraoperative Electron Radiotherapy

Recruiting
  • Locally Advanced Rectal Cancer
  • Locally Recurrent Rectal Cancer
  • Intraoperative Electron Radiotherapy (IOERT)
  • Extended Margin Surgery
  • Southampton, Hampshire, United Kingdom
    University Hospital Southampton NHS Foundation Trust
May 24, 2023

Para-aortic Lymph Node Metastasis of Cervical Cancer

Completed
  • Locally Advanced Cervical Cancer
  • surgical staging
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Jan 29, 2023

Whether Five Factors Affect PFS in Locally Advanced Cervical

Completed
  • Locally Advanced Cervical Cancer
  • Radiotherapy
    • Chongqing, Chongqing, China
      Chongqing Cancer Hospital
    Mar 19, 2023

    Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)

    Recruiting
    • Colon Cancer
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Aug 26, 2023

    Colorectal Cancer Trial (Serplulimab + FOLFOXIRI, Radiation therapy)

    Not yet recruiting
    • Colorectal Cancer
    • Serplulimab + FOLFOXIRI
    • Radiation therapy
    • (no location specified)
    Oct 24, 2023

    Non Small Cell Lung Cancer, ERBB2 Mutation-Related Tumors, RC48 Trial in Guanzhou (RC48+Tislelizumab+carboplatin,

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • Guanzhou, China
      SunYat-senU
    May 5, 2023

    Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)

    Recruiting
    • Colonic Neoplasms
    • +2 more
    • Nanning, Guangxi, China
      The First Affiliated Hospital of Guangxi Medical University
    Nov 9, 2023

    Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

    Recruiting
    • Gastric Cancer
    • sintilimab+metronomic PLOF
    • Shanghai, China
      Huashan Hospital, Fudan University
    Sep 22, 2023

    Gastric Cancer, GastroEsophageal Cancer, Fruquintinib Trial in Nanning (Fruquintinib + SOX)

    Recruiting
    • Gastric Cancer
    • +3 more
    • Fruquintinib + SOX
    • Nanning, China
      Guangxi Medical University Cancer Hospital
    Dec 2, 2022

    NSCLC Trial in Shanghai (SI-B001, SI-B003)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 10, 2023

    Esophageal Cancer Trial in Tianjin (Arm A, Arm B)

    Not yet recruiting
    • Esophageal Cancer
    • Arm A
    • Arm B
    • Tianjin, Tianjin, China
      Tianjin Cancer Hospital
    Sep 24, 2023

    Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)

    Recruiting
    • Cervical Cancer
    • +2 more
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute & Hospital
    Oct 16, 2023

    Sinonasal Undifferentiated Carcinoma Trial in Pavia (Pembrolizumab)

    Not yet recruiting
    • Sinonasal Undifferentiated Carcinoma
    • Pavia, Lombardia, Italy
      Istituti Clinici Scientifici Maugeri
    Jun 21, 2023